Screening for tuberkuloseinfektion før behandling med biologiske lægemidler

Keyphrases

• Anti-tumor Necrosis Factor (anti-TNF) 100%
• Tuberculosis Infection 100%
• Medical Therapy 100%
• Denmark 33%
• Clinical Setting 33%
• Latent Tuberculosis Infection 33%
• Risk of Progression 33%
• Chronic Inflammatory Diseases 33%
• TNF-α Antagonists 33%
• Active Tuberculosis 33%
• Interferon-gamma Release Assay 33%
• Chest X-ray 33%
• Tuberculosis Reactivation 33%
• Latent Tuberculosis 33%
• Preventive Chemotherapy 33%
• Anti-TNF Treatment 33%
• Tumor Necrosis Factor Antagonist 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Tumor Necrosis Factor 100%
• Combination Therapy 100%
• Tuberculosis 100%
• Latent Tuberculosis 40%
• Inflammatory Disease 20%
• Chemotherapy 20%
• Tumor Necrosis 20%
• Interferon 20%
• Postprimary Tuberculosis 20%